https://prabadinews.com/
  • October 8, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Study: High Similarity, Efficacy Between Tocilizumab Biosimilar and Reference Product in RA

Study: High Similarity, Efficacy Between Tocilizumab Biosimilar and Reference Product in RA

New research confirms that switching from tocilizumab to its biosimilar, Avtozma, maintains efficacy and safety in patients with rheumatoid arthritis (RA).

administrator

Related Articles